As I had mentioned in my statement, we think there's a real opportunity for the government to provide more information to consumers in a meaningful way to let them know how the substances have been assessed, what it means to them in terms of their own health, and what the outcomes are, or what the government is doing for particular substances that have been assessed.
Mr. Bossio had mentioned earlier about 1,4-dioxane. It was assessed in CMP 1. It was in batch seven. It was deemed to be safe and not to be affecting human health, or that it was not coming into the environment.
When one of those situations comes up where you're raising a valid concern in your riding, sir—and I do appreciate those comments—there might be an opportunity for a mechanism under CEPA that you could use to provide information, if there are concentrations of that substance that are higher than what was assessed, for it to be reassessed under the provisions of CEPA.